KRO Stock Analysis: Kronos Worldwide | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 936m USD | 12M Return: 42.4% | US50105F1057 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.15M
Qual. Beats: 0
Rev. Trend: 85.4%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kronos Worldwide, Inc. (NYSE: KRO) is a Dallas-based producer of titanium dioxide (TiO2) pigments, supplying rutile and anatase crystalline grades to manufacturers of paints, coatings, plastics, paper, fibers, and ceramics worldwide. The company also sells ilmenite feedstock, iron-based chemicals used in water treatment and pigments, and specialty chemicals serving electronics and pearlescent pigment applications, with products distributed under the KRONOS brand.
Founded in 1916 and operating as a subsidiary of Valhi, Inc., Kronos falls within the Materials sector and the Commodity Chemicals sub-industry, an area characterized by cyclical pricing driven by global supply-demand balances and concentrated end markets in industrial coatings and construction-related materials.
TiO2 manufacturing primarily relies on either the sulfate process or the chloride process, and the pigment is the most widely used white pigment globally due to its opacity and brightness, making demand closely tied to coatings, plastics, and paper output.
- TiO2 selling prices rise on tightening global pigment supply
- European paint demand weakens amid construction slowdown
- Chinese TiO2 exports pressure North American pricing margins
| Net Income: -109.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 6.41 > 1.0 |
| NWC/Revenue: 33.80% < 20% (prev 36.86%; Δ -3.06% < -1%) |
| CFO/TA 0.05 > 3% & CFO 87.7m > Net Income -109.4m |
| Net Debt (581.0m) to EBITDA (27.9m): 20.82 < 3 |
| Current Ratio: 3.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (115.1m) vs 12m ago 0.09% < -2% |
| Gross Margin: 11.81% > 18% (prev 18.88%; Δ -7.07% > 0.5%) |
| Asset Turnover: 105.5% > 50% (prev 97.51%; Δ 7.97% > 0%) |
| Interest Coverage Ratio: -0.69 > 6 (EBIT TTM -39.4m / Interest Expense TTM 57.1m) |
| A: 0.38 (Total Current Assets 942.6m - Total Current Liabilities 285.8m) / Total Assets 1.74b |
| B: -0.20 (Retained Earnings -346.0m / Total Assets 1.74b) |
| C: -0.02 (EBIT TTM -39.4m / Avg Total Assets 1.84b) |
| D: 0.76 (Book Value of Equity 751.0m / Total Liabilities 993.0m) |
| Altman-Z'' = 2.47 = A |
| DSRI: 1.10 (Receivables 393.3m/347.1m, Revenue 1.94b/1.89b) |
| GMI: 1.60 (GM 18.88% / 11.81%) |
| AQI: 0.83 (AQ_t 0.04 / AQ_t-1 0.05) |
| SGI: 1.03 (Revenue 1.94b / 1.89b) |
| TATA: -0.11 (NI -109.4m - CFO 87.7m) / TA 1.74b) |
| Beneish M = -2.49 (Cap -4..+1) = BBB |
As of October 07, 2026, the stock is trading at USD 7.86 with a total of 167,936 shares traded. Over the past week, the price has changed by -0.76%, over one month by -8.92%, over three months by +35.36% and over the past year by +42.37%.
Current recommended Stop Loss: 7.40 (which is 5.9% or 1.3 ATR below the current price).
Kronos Worldwide has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold KRO.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 8.5 | 8.1% |
P/E Forward = 4.878
P/S = 0.4816
P/B = 1.315
P/EG = 1.3556
Revenue TTM = 1.94b USD
EBIT TTM = -39.4m USD
EBITDA TTM = 27.9m USD
Long Term Debt = 569.6m USD (from longTermDebt, last quarter)
Short Term Debt = 3.90m USD (from shortTermDebt, last quarter)
Debt = 607.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 19.0m
Net Debt = 581.0m USD (calculated: Debt 607.6m - CCE 26.6m)
Enterprise Value = 1.52b USD (935.7m + Debt 607.6m - CCE 26.6m)
Interest Coverage Ratio = -0.69 (Ebit TTM -39.4m / Interest Expense TTM 57.1m)
EV/FCF = 22.31x (Enterprise Value 1.52b / FCF TTM 68.0m)
FCF Yield = 4.48% (FCF TTM 68.0m / Enterprise Value 1.52b)
FCF Margin = 3.50% (FCF TTM 68.0m / Revenue TTM 1.94b)
Net Margin = -5.63% (Net Income TTM -109.4m / Revenue TTM 1.94b)
Gross Margin = 11.81% ((Revenue TTM 1.94b - Cost of Revenue TTM 1.71b) / Revenue TTM)
Gross Margin QoQ = 18.42% (prev 16.34%)
Tobins Q-Ratio = 0.87 (Enterprise Value 1.52b / Total Assets 1.74b)
Interest Expense / Debt = 9.40% (Interest Expense 57.1m / Debt 607.6m)
Taxrate = 33.62% (7.70m / 22.9m)
NOPAT = -26.2m (EBIT -39.4m * (1 - 33.62%)) [loss with tax shield]
Current Ratio = 3.30 (Total Current Assets 942.6m / Total Current Liabilities 285.8m)
Debt / Equity = 0.81 (Debt 607.6m / totalStockholderEquity, last quarter 751.0m)
Debt / EBITDA = 20.82 (Net Debt 581.0m / EBITDA 27.9m)
Debt / FCF = 8.54 (Net Debt 581.0m / FCF TTM 68.0m)
Total Stockholder Equity = 763.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.94% (Net Income -109.4m / Total Assets 1.74b)
RoE = -14.34% (Net Income TTM -109.4m / Total Stockholder Equity 763.0m)
RoCE = -2.96% (EBIT -39.4m / Capital Employed (Equity 763.0m + L.T.Debt 569.6m))
RoIC = -1.82% (negative operating profit) (NOPAT -26.2m / Invested Capital 1.44b)
WACC = 8.66% (E(935.7m)/V(1.54b) * Re(10.24%) + D(607.6m)/V(1.54b) * Rd(9.40%) * (1-Tc(0.34)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 52.22 | Cagr: 0.04%
[DCF] Terminal Value 74.34% ; FCFF base≈68.0m ; Y1≈68.3m ; Y5≈72.3m
[DCF] Fair Price = 4.23 (EV 1.07b - Net Debt 581.0m = Equity 486.8m / Shares 115.1m; r=8.66% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.81 | # QB: 0
Revenue Correlation: 85.44 | Revenue CAGR: 5.75% | SUE: 0.81 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.19 | Chg30d=+60.08% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=0.40 | Chg30d=+165.73% | Revisions=+25% | GrowthEPS=+141.5% | GrowthRev=+11.1%
EPS next Year (2027-12-31): EPS=0.61 | Chg30d=+61.50% | Revisions=+25% | GrowthEPS=+54.0% | GrowthRev=+1.8%
[Analyst] Revisions Ratio: +50% (up=3, down=0)